ArticleHealth science reports2025
Prevalence, Risk Factors and Residential Variation Among HIV/TB Coinfected Mortality in Fenote Selam Hospital, Amhara Region: A Retrospective Study.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: HIV-TB co-infection is a worldwide health concern that arises when an individual has both HIV and tuberculosis (TB) infections. Ethiopia is one of the top 30 nations in the world with the highest rates of TB and HIV. The goal of this study was to determine the variables that influence adult HIV/TB coinfected patients' mortality as well as the nutritional differences in mortality by level of residency. Method: In this study, 417 patients that met our criteria were included in this study. We employed a multilevel logistic regression model. Result: 12.9% of HIV/TB coinfected patients died during the research period. It was discovered that important predictors of HIV/TB coinfected mortality included functional status, age of patients, WHO clinical stages, nutritional status, CD4 levels, regimen, and BMI. In our study, patients who fell into the bedridden functional status group, those who were in the fourth WHO clinical stage (stage IV), those who were older, those whose therapies were second-line regimens, and those with low CD4 cell counts were greater at risk of passing away. Conclusion: This study showed that, individuals with HIV/TB co-infection were more likely to die and that this risk varied depending on the patient's place of residency (rural areas were more at risk).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.